Laparoscopic versus open colectomy for colon cancer in an older population: a cohort study by Linda C Cummings et al.
RESEARCH Open Access
Laparoscopic versus open colectomy for colon
cancer in an older population: a cohort study
Linda C Cummings1*, Conor P Delaney2 and Gregory S Cooper1
Abstract
Background: Laparoscopic colectomy for colon cancer has been compared with open colectomy in randomized
controlled trials, but these studies may not be generalizable because of strict enrollment and exclusion criteria
which may explicitly or inadvertently exclude older individuals due to associated comorbidities. Previous studies of
older patients undergoing laparoscopic colectomy have generally focused on short-term outcomes. The goals of
this cohort study were to identify predictors of laparoscopic colectomy in an older population in the United States
and to compare short-term and long-term outcomes.
Methods: Patients aged 65 years or older with incident colorectal cancer diagnosed 1996-2002 who underwent
colectomy within 6 months of cancer diagnosis were identified from the linked Surveillance, Epidemiology, and
End Results-Medicare database. Laparoscopic and open colectomy patients were compared with respect to length
of stay, blood transfusion requirements, intensive care unit monitoring, complications, 30-day mortality, and long-
term survival. We adjusted for potential selection bias in surgical approach with propensity score matching.
Results: Laparoscopic colectomy cases were associated with left-sided tumors; areas with higher population
density, income, and education level; areas in the western United States; and National Cancer Institute-designated
cancer centers. Laparoscopic colectomy cases had shorter length of stay and less intensive care unit monitoring.
Although laparoscopic colectomy patients (n = 424) had fewer complications (21.5% versus 26.3%), lower 30-day
mortality (3.3% versus 5.8%), and longer median survival (6.6 versus 4.8 years) compared with open colectomy
patients (n = 27,012), after propensity score matching these differences disappeared.
Conclusions: In this older population, laparoscopic colectomy practice patterns were associated with factors which
likely correlate with tertiary referral centers. Although short-term and long-term survival are comparable,
laparoscopic colectomy offers shorter hospitalizations and less intensive care.
Background
Over the past decade, laparoscopic and laparoscopically-
assisted resection of colon cancer have emerged as pro-
mising alternatives to open colectomy. Benefits of
laparoscopic colectomy (LC) over open colectomy (OC)
include decreased operative blood loss, shorter hospitali-
zation, and improved pain control [1-4]. LC is selectively
practiced with T4 lesions, obstruction, or perforation,
and may be challenging due to adhesions or morbid
obesity. New staging information or technical difficulties
arising during laparoscopy may lead to conversion to
open colectomy, with rates of 5%-21% [2,5,6].
Randomized controlled trials (RCT) have shown no
long-term survival difference between LC and OC
[5,7-9] or, in one single-center trial, better cancer-
related survival with LC [10]. However, these studies
may not be generalizable because of strict inclusion or
exclusion criteria which may explicitly or inadvertently
exclude older individuals due to associated comorbid-
ities. Individuals aged ≥ 65 years nevertheless have the
highest incidence of colorectal cancer [11]. A recent
study applying inclusion and exclusion criteria from two
of these RCTs to a prospective colectomy database
found that excluded patients were older [12]. Whilst
older patients might benefit most from the less invasive
approach offered by laparoscopic colectomy because of
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limited functional reserve [13], some surgeons still have
concerns that they may actually be disadvantaged by the
longer operative times usually described with this
approach.
Previous studies of older patients undergoing laparo-
scopic colectomy, often defined as patients aged ≥ 70
years, have generally focused on short-term outcomes
[14,15]. Our study aimed to identify factors associated
with laparoscopic colectomy in older patients (aged ≥ 65
years) and to compare both short-term and long-term out-
comes. We used the linked Surveillance, Epidemiology,
and End Results (SEER)-Medicare database to permit
comparisons of short-term outcomes such as length of
stay, blood transfusions, intensive care monitoring, com-
plication rates, and 30-day mortality, but also permit eva-
luation of long-term survival. A propensity score model
incorporating patient factors including comorbidities and
hospital characteristics was used to control for potential
selection bias in assignment of surgical approach.
Methods
Patients and Data Sources
This study was approved by the National Cancer Institute
(NCI), SEER, and University Hospitals Case Medical
Center’s Institutional Review Board. Informed consent
was not obtained due to lack of patient identifiers. NCI’s
SEER tumor registry collects reliable patient-specific
information from cancer registries [16]. Over the study
period, SEER expanded to cover 25% of the U.S. popula-
tion. Linking SEER to Medicare claims creates a joint
database of Medicare beneficiaries (predominantly aged ≥
65 years) who were diagnosed with cancer while living in
SEER areas.
Patients aged ≥ 65 years with incident colon cancer diag-
nosed 1996–2002 presenting with localized, regional, or
distant disease according to SEER who underwent colect-
omy as indicated by Medicare claims were included.
Health Maintenance Organization enrollees and Medicare
Part B non-participants from 12 months before to 3
months after diagnosis were excluded due to lack of claims
data regarding outpatient and physician services [16].
Unstaged patients and those with carcinoma in situ, prior
malignancy, familial adenomatous polyposis, or inflamma-
tory bowel disease were excluded. Patients with transverse
colon or rectal carcinoma were excluded as per prior
RCTs [5,8,17].
Measures
Patient and tumor characteristics
Demographic data (age, race, marital status, and gen-
der), lymph node involvement, and stage at presentation
were obtained from SEER. Comorbidities were assessed
using a modified (malignancy and metastatic cancer
excluded) version of the Deyo adaptation of the
Charlson comorbidity index [18] based on International
Classification of Diseases, 9th revision-clinical modifica-
tion (ICD-9-CM) diagnosis codes from ≥ 1 inpatient
(MedPAR) or ≥ 2 outpatient (Standard Analytical File)
claims filed within a year to a month prior to cancer
diagnosis [19]. Tumor site was dichotomized as left-
sided (splenic flexure to sigmoid colon) or right-sided
(cecum to hepatic flexure).
Colectomy
Colectomies occurring 1 month before to 6 months after
cancer diagnosis were identified from MedPAR claims
dated 1995-2003 using the following ICD-9-CM procedure
codes: right hemicolectomy (45.73), left hemicolectomy
(45.75), or sigmoidectomy (45.76). Colectomy claims
including an ICD-9-CM procedure code for laparoscopy
(54.21) with the same procedure date were considered
laparoscopic [20-24]. Colectomy claims with ICD-9-CM
diagnosis codes V64.4 or V64.41 (conversion of a laparo-
scopic procedure to open) were analyzed as laparoscopic
colectomies similar to an intention-to-treat analysis. We
could not distinguish laparoscopic from laparoscopic
hand-assisted colectomies. Emergent cases, defined by
admitting diagnoses of obstruction (560.89, 560.9), per-
foration (569.83), or peritonitis (567.0, 567.2x, 567.8x,
567.9), were included.
Hospital/Geographic Characteristics
Indirect medical education payment on a colectomy claim
was considered evidence of performance at a teaching hos-
pital [25,26]. Urban hospital and NCI cancer center desig-
nation were obtained from NCI’s Hospital Files (1996,
1998, 2000-2003). U.S. Census 2000 data were obtained
from the Patient Entitlement and Diagnosis Summary File
regarding census tract median income, education level (%
of adults with high school only education), and population
density based on patient residence. Zip code data were
imputed for missing census tract-level variables. SEER
registries were grouped geographically into 5 regions: 1)
West (San Francisco, Los Angeles, San Jose, Greater Cali-
fornia, Seattle, Hawaii), 2) Mountain (Utah, New Mexico),
3) Midwest (Detroit, Iowa), 4) Northeast (Connecticut,
New Jersey), and 5) South (Kentucky, Louisiana, Georgia).
Length of Stay, Transfusion Requirements, Intensive Care
Monitoring, and Complications
MedPAR length of hospitalization, blood pints furnished,
and intensive care indicator variables were used to deter-
mine length of hospitalization, transfusions, and intensive
care monitoring, respectively. Colectomy claims were
evaluated for complications using ICD-9-CM diagnosis
codes for accidental laceration (998.2, E870.0), postopera-
tive hemorrhage (998.1), posthemorrhagic anemia
(285.1), anesthetic reaction (995.4, E938, E945.2), wound
dehiscence (998.3), peritonitis (567.2), ileus (560.1), gas-
trointestinal hemorrhage (578, 578.0, 578.1, 578.9), gas-
trointestinal complications (997.4), intestinal fistula
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(569.81), stomach or duodenal fistula (537.4), and post-
operative infection (998.5).
Chemotherapy Use
MedPAR, National Claims History, and Standard Analyti-
cal File claims were evaluated for chemotherapy adminis-
tration occurring from 1 month prior to 6 months after
cancer diagnosis using the following: chemotherapy-
related ICD-9-CM procedure (99.25) and diagnosis codes
(V58.1, V58.11, V67.2, V66.2); Healthcare Common Proce-
dure Coding System codes for chemotherapy administra-
tion (Q0083-Q0085) and chemotherapeutic agents (J9000-
J9999); and revenue center codes for chemotherapy (0331,
0332, 0335). As previously validated, chemotherapy use
was imputed for claims consistent with chemotherapy
administration or encounter where no drug was specified
[27].
Statistical Analysis and Definitions
Perioperative mortality was defined as death within 30
days of colectomy. Continuous covariates were compared
using independent samples t-tests or Wilcoxon rank sum
tests as appropriate. Categorical covariates were compared
with chi-square tests. Unadjusted and adjusted logistic
regression was performed to identify factors associated
with laparoscopic colectomy. Data were analyzed with
SAS (9.1 for Windows; SAS Institute Inc., Cary, NC).
Survival Analysis
Survival time was measured from colectomy to date of
death. Survival times were administratively censored on
December 31st, 2004. The Kaplan-Meier method was used
to estimate survivor functions. Survival curves were com-
pared with the log-rank test. We developed univariate and
multivariate Cox proportional hazards models as well as a
multivariate Cox proportional hazards. Covariates were
assessed for time dependence to evaluate potential propor-
tional hazards assumption violations.
Propensity Score Analysis
Because of nonrandom treatment allocation, a propensity
score (PS) model was used to reduce bias resulting from
differences in observed covariates between LC and OC
groups. A propensity score is the conditional probability
that a patient will be assigned to a particular treatment
[28], in this case laparoscopic colectomy. To generate pro-
pensity scores, a non-parsimonious logistic regression
model incorporating variables felt to be LC predictors and
clinically plausible interaction terms was developed with
laparoscopic colectomy as the dependent variable. LC
patients were matched 1:1 to OC patients by propensity
scores, resulting in 424 OC patients (designated the OC-
Matched, or OC-M subset) with the same pre-intervention
probability of undergoing LC as the 424 LC patients. Con-
tinuous outcomes were compared in the PS-matched
groups using paired t-tests or Wilcoxon signed rank test
as appropriate.
Results
27,436 patients who met inclusion and exclusion criteria
for incident colon cancer undergoing colectomy were
identified from the SEER-Medicare database. Of these,
27,012 (98.5%) underwent open colectomy. Only 424 cases
(1.5%) were identified as LC, of which 13.7% (n = 58) were
converted to open. Mean age at cancer diagnosis was 77.9
years (standard deviation [SD] 7.1), reflecting an older
population. Patients were predominantly female (58.3%, n
= 16,006) and white (86.3%, n = 23,673). Blacks comprised
7.4% of the cohort (n = 2,020), and individuals of other/
unknown ethnicity the remaining 6.4%. Only 21.5% (n =
5,889) of patients had a Charlson score ≥ 1. 41.6% of all
cases presented with localized stage (n = 11,407), 44.0%
with regional stage (n = 12,077), and 14.4% with distant
stage (n = 3,952). 59.0% of colectomies occurred in cases
diagnosed in 2000 or later, reflecting SEER’s expansion in
2000. 50.1% of cases (n = 13,741) occurred in teaching
hospitals.
Baseline characteristics of the cohort by surgical
approach are shown (Table 1) with corresponding
p-values. The groups were similar with respect to age,
race, gender, marital status, comorbidities, and disability
status. LC patients were less likely to have left-sided
tumors (p = 0.001). The LC rate increased over the study
period from 1.0% (30/2,908) of colectomies in 1996 to
1.8% (101/5,465) in 2002 (p = 0.001). LC cases were asso-
ciated with areas with higher income, better education,
higher population density, and SEER registries in the
western U.S., especially California.
OC cases took place in 1,135 of 1,136 hospitals in the
cohort, compared with 174 hospitals for LC cases. LC
cases were more common than OC cases in teaching hos-
pitals (53.3% versus 50.0%) and were associated with
urban hospitals and NCI-designated cancer centers, but
not teaching hospitals. Accordingly, among hospitals at
which LC cases were performed, 92.5% (n = 161) were
urban and 4.6% (n = 8) were NCI-designated cancer cen-
ters, compared with 73.1% (n = 830) and 2.3% (n = 26),
respectively, for hospitals at which OC cases were
performed.
Stage at Presentation, Nodal Status and Chemotherapy
Receipt
LC patients presented with earlier stage than OC patients
(p = 0.005). Localized disease patients comprised the lar-
gest proportion (46.9%) in the LC group, compared with
regional disease patients (44.0%) in the OC group. Distant
disease patients comprised 14.5% (n = 3,908) of the OC
group, versus only 10.4% of LC patients (n = 44). The pro-
portion of node-positive cases was similar between LC and
OC groups (34.9% versus 38.8%, respectively; p = 0.24), as
was receipt of chemotherapy within 6 months of diagnosis
(27.6%, LC versus 28.0%, OC).
Cummings et al. World Journal of Surgical Oncology 2012, 10:31
http://www.wjso.com/content/10/1/31
Page 3 of 10
Factors associated with Laparoscopic Colectomy
On univariate analysis, factors associated with laparo-
scopic colectomy included California residence, resi-
dence in a large metropolitan area, National Cancer
Institute cancer center designation, urban hospital set-
ting, localized stage, and residence in areas with higher
census tract density and census tract median income. In
addition, as the difference between the year of cancer
diagnosis and the year 1996 increased, the associated
odds ratio increased, reflecting the increase in the rate
of laparoscopic colectomy over time. Left-sided tumors,
regional or distant stage, and areas with lower census
tract education were less likely to be associated with
laparoscopic colectomy. On multivariate analysis, factors
Table 1 Baseline Characteristics in Overall Cohort by Surgical Approach
Variable LC (n = 424) OC (n = 27,012) P valuea
Mean Age at Dx ± SD, years 77.5 ± 7.3 77.9 ± 7.1 0.034
Female (%) 234 (55.2) 15,772 (58.4) 0.185
Mean Charlson score ± SD 0.31 ± 0.83 0.38 ± 0.90 0.099
Disabled (%) 22 (5.2) 1,743 (6.5) 0.293
Weekend day admission (%) 67 (15.8) 4,334 (16.0) 0.893
Race
White (%) 370 (87.3) 23,303 (86.3)
African-American (%) 35 (8.3) 1,985 (7.4) 0.236
Other (%) 19 (4.5) 1,724(6.4)
Marital status
Married (%) 210 (49.5) 13,051 (48.3)
Separated/Not married (%) 200 (47.2) 12,939 (47.9) 0.807
Missing (%) 14 (3.3) 1,022 (3.8)
Emergent presentation (%) 12 (2.8) 1,272 (4.7) 0.069
Left-sided tumor (%) 125 (29.5) 10,016 (37.1) 0.001
Large metro area (%) 309 (72.9) 14,775 (54.7) < 0.001†
Data for patient’s census tract
Income,b $US 56,075 ± 27,809 50,024 ± 22,898 < 0.001
Education levelc ± SD 23.0 ± 9.6 27.4 ± 10.0 < 0.001
Mean census tract densityd ± SD 2,247 ± 3,298 1,768 ± 2,661 0.003
Census tract data imputed (%) 28 (6.6) 2,474 (9.2) 0.070
Geographic region of SEER Registry
West (%) 223 (52.6) 9,286 (34.4)
Mountain (%) 27 (6.4) 1,490 (5.5)
Midwest (%) 44 (10.4) 6,807 (25.2) < 0.001
Northeast (%) 75 (17.7) 5,789 (21.4)
South (%) 55 (13.0) 3,640 (13.5)
Hospital Characteristics
Teaching hospital (%) 226 (53.3) 13,515 (50.0) 0.182
Urban hospital (%) 402 (94.8) 23,256 (86.1) < 0.001
NCI Cancer Center (%) 24 (5.7) 728 (2.7) < 0.001
a P value from independent sample t-tests for continuous variables or chi-square tests for categorical variables
bCensus tract median income
cMean % of individuals with high school only education in the census tract
dIn persons per square kilometer
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that remained associated with laparoscopic colectomy in
this elderly population included California residence,
residence in a large metropolitan area, and year of can-
cer diagnosis relative to 1996, while left-sided tumors,
regional or distant stage, and areas with lower census
tract education were less likely to be associated with
laparoscopic colectomy (Table 2).
Short-Term Outcomes
Median length of stay in the LC group was 7 days (mean
8.3 days, SD 6.2). Median length of stay in the OC group
was 8 days (mean 10.6 days, SD 7.6). The mean number of
blood pints furnished did not differ between LC and OC
groups (LC 0.13, OC 0.24). Among LC cases, 25.2% (n =
107) had intensive care unit (ICU) monitoring during the
hospitalization, compared with 31.5% (n = 8,517) in the
OC group (p = 0.006). OC patients had a higher complica-
tion rate than LC patients (26.3% versus 21.5%, p = 0.03).
Rates of ileus or gastrointestinal complications, the most
common complications, did not differ between the LC and
OC groups. The overall OC group had a significantly
higher rate of postoperative hemorrhage or posthemorrha-
gic anemia than the LC group (9.9% versus 5.7%, p =
0.003). 30-day mortality was 3.3% (n = 14) in the LC
group, significantly lower than the overall OC group rate
of 5.8% (n = 1,565; p = 0.03).
Long-Term Survival
Median survival was 6.6 years in the LC group (95% CI
5.2, xxx.) and 4.8 years in the overall OC group (95% CI
4.6, 4.9). Two-year, three-year, and 5-year survival rates
were better in the LC than the OC group (75.0% versus
68.3%; 67.0% versus 60.2%; and 55.8% versus 48.9%,
respectively). The log-rank test comparing long-term sur-
vival curves stratified by surgical group (Figure 1) was sta-
tistically significant (p = 0.002).
Demographic, tumor, hospital, and geographic charac-
teristics in the overall cohort were next examined in
univariate analysis for significant differences in time to
death (Table 3). Laparoscopic colectomy was associated
with improved survival compared with open colectomy
(HR 0.79, 95% CI 0.68, 0.92). However, after adjusting
for comorbidities, demographic characteristics, and
tumor characteristics, LC was no longer associated with
improved survival compared with OC. The final multi-
variate Cox proportional hazards model incorporating
interaction terms and time-dependent covariates is
shown (Table 4).
Propensity Score Analysis
A non-parsimonious multivariable logistic propensity
model was created incorporating all observed covariates
potentially associated with LC that would have been
known prior to decision-making regarding surgical
approach. Through this model propensity scores reflect-
ing the probability of undergoing LC were generated. LC
patients were then matched 1:1 to OC patients on the
basis of the propensity score, and the matched cohort
was re-analyzed. After PS matching, mean length of stay
remained significantly longer with the OC-Matched (OC-
M) subset (10 days, SD 8.9) compared with the LC group
(p < 0.001). As before, blood pints furnished did not dif-
fer after PS matching (LC 0.13, OC-M 0.17). ICU Moni-
toring remained more common in the OC-M group after
PS matching (OC-M, 33.7% versus LC, 25.2%). After PS
matching, complication rates were no longer different
between the two groups (OC-M, 26.7% versus LC, 21.5%,
p = 0.09). Likewise, the rate of postoperative hemorrhage
or posthemorrhagic anemia was no longer significantly
different between groups (OC-M, 9.0% versus LC, 5.7%).
Differences in 30-day mortality disappeared after PS
matching (OC-M, 4.3% [n = 18]).
Median survival improved from 4.8 years in the overall
OC group to 5.1 years (95% CI 3.9, 6.1) in the OC-M
subset. Likewise, 2-year, 3-year, and 5-year survival in
the OC-M subset were also improved compared to the
overall OC group (2-year survival, 71.2% versus 68.3%;
3-year survival, 63.4% versus 60.2%; 5-year survival,
Table 2 Multivariate Analysis of Factors Associated with Laparoscopic Colectomy
Variable Estimate OR 95% CI P value*
Year of diagnosis relative to 1996 0.0891 1.093 (1.039, 1.150) 0.001
Stage
Regional (relative to localized) -0.1583 0.854 (0.696, 1.047) 0.01°
Distant (relative to localized) -0.4730 0.623 (0.448, 0.866)
Left-sided tumor -0.3260 0.722 (0.584, 0.892) 0.003
California residence 0.6293 1.876 (1.499, 2.349) < 0.0001
Large metropolitan area 0.4975 1.645 (1.308, 2.068) < 0.001
Education levela -0.0221 0.978 (0.967, 0.990) 0.0002
NCI cancer center designation 0.8637 2.372 (1.555, 3.619) < 0.001
aMean % of individuals with high school only education in the census tract
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50.0% versus 48.9%). Kaplan-Meier survival curves stra-
tifying survival by surgical treatment in the PS matched
cohort are shown (Figure 2). The log-rank test was not
statistically significant (p = 0.095). Table 5 displays the
final Cox proportional hazards model including interac-
tions and time-dependent variables. As with the multi-
variate Cox proportional hazards model in the overall
cohort, laparoscopic colectomy was not associated with
improved survival (HR 0.94, 95% CI 0.76, 1.15).
Discussion
This project identified factors associated with laparo-
scopic colectomy in an older population and compared
short-term and long-term outcomes. The rate of LC in
the overall cohort was low at 1.5%, potentially due to
the perceived morbidity of performing LC in elderly
patients. Population-based studies using the National
Cancer Data Base and the Nationwide Inpatient Sample
over a similar time period found LC rates of 4.6% and
3.3%, respectively [20,29]. However, these studies
included patients aged < 65, and the Nationwide Inpati-
ent Sample study relied on a cancer diagnosis code for
the hospitalization rather than cancer registry data.
Notably, in the current study, LC cases were more likely
to occur at hospitals with NCI cancer center designation
or in individuals residing in areas with higher education
levels or larger populations (Table 2). These factors
probably reflect tertiary care practice patterns.
Consistent with RCT results [2,5], LC was associated
with shorter hospitalizations. Relatively high ICU moni-
toring rates were seen in the two treatment groups, with
higher rates in the OC and OC-M groups (31.5% and
33.7%, respectively) than LC (25.2%). Direct comparison
with RCTs is not possible due to lack of corresponding
RCT data. Nonetheless, these results are intriguing given
the older population in this study. Although a laparo-
scopic approach theoretically may be associated with a
higher risk of cardiopulmonary complications (and hence
more intensive monitoring) due adverse effects of pneu-
moperitoneum on the cardiovascular system, our analysis
does not support such a hypothesis.
Complication rates were relatively low except for bleed-
ing, ileus, and gastrointestinal complications. In particu-
lar, the postoperative infection rate was 0.2% in the OC
group, with no cases in the LC group. The wound infec-
tion rate in RCTs has ranged between 3%-12% [2,30].
Figure 1 Kaplan-Meier Survival Curves by Surgical Approach.
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Postoperative infection was likely undercoded in this
study, and discharged patients that were readmitted with
infection were not captured. Although several RCTs have
demonstrated decreased blood transfusion requirements
with LC [2,6,30], in the current study, transfusion
requirements did not differ by surgical group. 30-day
mortality rates (ranging from 3.3% in the LC group to
5.8% in the overall OC group) in our study were similar
to the rate of 5.6% previously reported in an analysis by
Rabeneck et al. of Veterans Affairs patients aged ≥ 65
years undergoing colon cancer resection [31].
The 5-year survival rates in our study ranged between a
low of 48.9% for the overall OC group to 55.8% for the
LC group. These rates are much lower than the 5-year
overall survival rates of 74.6%-76.4% reported from the
COST study, a randomized controlled trial comparing
laparoscopically assisted colectomy to open colectomy
[7]. The median age of patients in the COST study was
younger than that in the current study [5]. The lower 5-
year survival in the current study probably reflects
increased mortality and comorbidities in this older popu-
lation and the fact that this series was not a selected
group of patients for a randomized controlled trial. Con-
sistent with our results, the Rabeneck study reported a 5-
year overall survival rate of 46.6% in patients aged ≥ 65
years versus 57.6% in patients aged < 65 years following
resection for colon cancer [31].
Long-term survival appeared more favorable in the LC
group than the overall OC group on Kaplan-Meier ana-
lysis (Figure 2). These results were likely partially attri-
butable to confounding by stage and nodal status, both
of which favored the LC group. An adjusted survival
Table 3 Univariate Predictors of Long-Term Survival in Overall Cohort
Variable Hazard Ratio 95% CI P valuea
Laparoscopic Colectomy 0.787 0.677-0.916 0.0012
Female Gender 0.936 0.905-0.968 0.0002
Black Race 1.204 1.132-1.280 < 0.0001b
Other Race 0.886 0.825-0.952
Emergent Presentation 1.874 1.751-2.006 < 0.0001
Weekend Admission 1.120 1.070-1.173 < 0.0001
Large Metro Area 1.085 1.049-1.123 < 0.0001
Left-sided Tumor 0.935 0.903-0.968 0.0001
California Registry 1.005 0.967-1.044 0.8065
Disabled 1.268 1.189-1.352 < 0.0001
Positive Nodes 2.337 2.259-2.417 < 0.0001
Teaching Hospital 0.981 0.948-1.014 0.2564
Separated/Not Married 1.385 1.338-1.433 < 0.0001c
Marital Status Unknown 1.171 1.069-1.283
Chemotherapy Receipt 0.923 0.889-0.959 < 0.0001
Regional Stage Disease 1.686 1.620-1.755 < 0.0001d
Distant Stage Disease 6.33 6.043-6.637
Urban Hospital 1.013 0.964-1.064 0.6085
NCI Cancer Center 0.854 0.767-0.950 0.0028
Age at dx (1-year change) 1.050 1.048-1.053 < 0.0001
Year of dx relative to 1996 0.995 0.986-1.004 0.3220
Census tract median income ($1,000 change) 0.997 0.997-0.998 < 0.0001
Census tract % high school only education 1.003 1.001-1.004 0.0012
Census tract density (1,000 persons/unit change) 1.005 1.003-1.007 < 0.0001
Charlson index (1-unit change) 1.244 1.225-1.264 < 0.0001
Dx, Diagnosis.
a Partial likelihood ratio test.
b Compared with white race.
c Compared with married.
d Compared with localized stage.
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analysis using Cox proportional hazards models in the
overall cohort revealed no survival difference. Similarly,
in the PS matched cohort, long-term survival did not
differ by surgical approach. Our findings are therefore
consistent with most previous RCTs. In contrast, a prior
population-based study found higher 5-year survival
rates with laparoscopic-assisted colectomy (64.1%) com-
pared to open colectomy (58.5%) [29]. However, those
results were not adjusted for comorbidities which may
preferentially affect older individuals. Our results sug-
gest that a laparoscopic approach does not seem to
impact long-term survival compared with an open
approach in older patients.
Our study had several strengths that should be noted.
Its focus on older individuals is particularly relevant due
to the aging population and the predominance of color-
ectal cancer in this age range. This study analyzed fac-
tors associated with the use of laparoscopic colectomy
for colon cancer in older individuals; previous studies of
laparoscopic colectomy in older individuals have often
been limited to single centers. The SEER-Medicare data-
set provided information on individuals from a variety
Table 4 Final Cox Proportional Hazards Model in Overall
Cohort
Variable Hazard Ratio 95% CI P valuea
Laparoscopic Colectomy 0.902 0.776-1.050 0.1838
Female Gender 0.846 0.818-0.876 < 0.0001
Black Race 1.174 1.104-1.249 < 0.0001b
Emergent Presentation 1.419 1.325-1.519 < 0.0001
Positive Nodes 1.897 1.812-1.986 < 0.0001
Chemotherapy Receipt 3.380 2.040-5.600 < 0.0001
Chemotherapy*ln(survival time) 1.356 1.314-1.399 < 0.0001
Regional Stage 1.264 1.201-1.329 < 0.0001c
Distant Stage 5.560 5.236-5.903 < 0.0001c
Regional Stage*ln(survival time) 0.967 0.941-0.993 0.0127
Distant Stage*ln(survival time) 1.037 1.006-1.068 0.0184
Age at Dx (1-year change) 1.056 1.053-1.059 < 0.0001
Age at Dx*ln(survival time) 1.003 1.001-1.004 0.0011
Age at Dx*Chemotherapy 0.978 0.972-0.985 < 0.0001
Charlson index (1-unit change) 1.257 1.237-1.277 < 0.0001
Dx, Diagnosis.
a Wald test.
b Compared with white/other race.
c Compared with localized stage.
Figure 2 Kaplan-Meier Survival Curves by Surgical Approach After Propensity Score Matching.
Table 5 Final Cox Proportional Hazards Model in
Propensity Score-Matched Cohort
Variable Hazard Ratio 95% CI P valuea
Laparoscopic Colectomy 0.936 0.760-1.152 0.5301
Female Gender 0.996 0.805-1.232 0.9693
Positive Nodes 2.028 1.504-2.735 < 0.0001
Chemotherapy Receipt 0.550 0.423-0.717 < 0.0001
Chemotherapy*ln(survival time) 1.460 1.222-1.744 < 0.0001
Regional Stage disease 1.520 1.103-2.095 0.0105b
Distant Stage disease 6.463 4.409-9.472 < 0.0001b
a Wald test.
b Compared with localized disease.
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of areas across the United States and allowed identifica-
tion of comorbid conditions diagnosed prior to cancer
diagnosis which could have affected survival.
This study nonetheless had several limitations. First,
Medicare claims were used to identify LC cases because
SEER does not differentiate laparoscopic from open surgi-
cal approach. This approach may have led to LC underde-
tection. Of note, a recent analysis of SEER-Medicare data
including cases diagnosed through 2005 evaluating out-
comes after colorectal cancer resection found that laparo-
scopic cases comprised < 2% of cases [32]. Second, the
unvalidated blood pints furnished variable may be under-
coded and might not correlate with ICD-9-CM blood
transfusion procedure codes [33]. We also used procedure
codes to measure ICU monitoring but these codes have
not been well validated. Third, use of the combination of
ICD-9-CM procedure codes for colectomy and laparo-
scopy on the same date to indicate laparoscopic colectomy
has not been validated, although similar approaches have
been utilized in other studies [20-24]. Fourth, except for
incorporation of hospital characteristics, this analysis did
not account for clustering of LC cases in a subset of
hospitals.
Conclusions
In this analysis of older individuals with colon cancer,
laparoscopic colectomy was associated with factors that
probably correlate with tertiary care practice patterns.
Laparoscopic colectomy was associated with shorter hos-
pitalizations and less ICU monitoring. Although 5-year
survival was lower than that reported in RCTs, laparo-
scopic colectomy was not associated with worse survival
compared with open colectomy. Laparoscopic colectomy
appears to be a reasonable option in older patients with
colon cancer which reduces hospital stay and intensive
care use.
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